HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations

Published on January 6, 2025

25 million equity purchases to fund planned HOPE clinic acquisitions. Company management anticipates this new capital in combination with